Literature DB >> 23108808

Risk factors for complications of ERCP in primary sclerosing cholangitis.

S Ismail1, L Kylänpää, H Mustonen, J Halttunen, O Lindström, K Jokelainen, M Udd, M Färkkilä.   

Abstract

BACKGROUND AND STUDY AIMS: Endoscopic retrograde cholangiographic pancreatography (ERCP) is the most accurate technique for surveillance of patients with primary sclerosing cholangitis (PSC). Our aim was to evaluate risk factors for complications of ERCP in patients with PSC. PATIENTS AND METHODS: In 2007 - 2009 we performed 441 ERCPs in patients with PSC. The primary tools for ERCP were a guide wire and papillotomy knife to gain access into the biliary duct. If the primary cannulation failed, and the wire went only into the pancreatic duct, pancreatic sphincterotomy was performed. If necessary, a further oblique cut with a needle knife was done in order to expose the biliary duct.
RESULTS: Primary cannulation was successful in 389 patients (88.2 %). Of these, 147 (37.8 %) had had biliary sphincterotomy performed previously. In the group with failed primary cannulation, access into the biliary duct was achieved after pancreatic sphincterotomy in 52 patients. In 11 of these, a further cut with a needle knife was performed. Post-ERCP pancreatitis (PEP) was diagnosed in 31 patients (7.0 %). Factors predicting PEP were female sex (odds ratio [OR] 2.6, P = 0.015) and a guide wire in the pancreatic duct (OR 8.2, P < 0.01). Previous biliary sphincterotomy was a protective factor (OR 0.28, P = 0.02). The risk of PEP increased with the number of times the wire accidentally passed into the pancreatic duct (P < 0.001). Cholangitis developed in 6 patients (1.4 %).
CONCLUSIONS: In patients with PSC the incidence of ERCP complications remained relatively low. The complication risk increased with the complexity of cannulation. In a patient with PSC in whom follow-up ERCP is planned, biliary sphincterotomy should be considered, as it may protect against PEP. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2012        PMID: 23108808     DOI: 10.1055/s-0032-1325677

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  17 in total

1.  What is the current role of endoscopy in primary sclerosing cholangitis?

Authors:  Benjamin Tharian; Nayana Elizabeth George; Tony Chiew Keong Tham
Journal:  World J Gastrointest Endosc       Date:  2015-08-10

2.  Clinical course and prognosis of pediatric-onset primary sclerosing cholangitis.

Authors:  Andrea Tenca; Martti Färkkilä; Johanna Arola; Tytti Jaakkola; Roberto Penagini; Kaija-Leena Kolho
Journal:  United European Gastroenterol J       Date:  2015-10-30       Impact factor: 4.623

3.  Diclofenac does not reduce the risk of acute pancreatitis in patients with primary sclerosing cholangitis after endoscopic retrograde cholangiography.

Authors:  Vilja Koskensalo; Andrea Tenca; Marianne Udd; Outi Lindström; Mia Rainio; Kalle Jokelainen; Leena Kylänpää; Martti Färkkilä
Journal:  United European Gastroenterol J       Date:  2020-03-08       Impact factor: 4.623

Review 4.  Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management.

Authors:  John E Eaton; Jayant A Talwalkar; Konstantinos N Lazaridis; Gregory J Gores; Keith D Lindor
Journal:  Gastroenterology       Date:  2013-07-01       Impact factor: 22.682

5.  A comparison of balloon- versus stent-based approach for dominant strictures in primary sclerosing cholangitis: a meta-analysis.

Authors:  Amaninder S Dhaliwal; Yassin Naga; Daryl Ramai; Syed M Saghir; Sarav G Daid; Banreet Dhindsa; Andrew Ofosu; Pushpak Taunk
Journal:  Ann Gastroenterol       Date:  2022-03-25

Review 6.  Primary sclerosing cholangitis: diagnosis and treatment.

Authors:  Holger Lutz; Christian Trautwein; Jens W Tischendorf
Journal:  Dtsch Arztebl Int       Date:  2013-12-23       Impact factor: 5.594

7.  Clinical outcomes and resource utilization analysis in patients with rheumatoid arthritis undergoing endoscopic retrograde cholangiopancreatography.

Authors:  Ahmed Ahmed; Aaron Kahlam; Suraj Pai; Sushil Ahlawat
Journal:  JGH Open       Date:  2021-02-19

8.  New approach to decrease post-ERCP adverse events in patients with primary sclerosing cholangitis.

Authors:  Udayakumar Navaneethan; Dennisdhilak Lourdusamy; Norma G Gutierrez; Xiang Zhu; John J Vargo; Mansour A Parsi
Journal:  Endosc Int Open       Date:  2017-08-07

9.  Length of stay overestimates severity of post-ERCP pancreatitis: Is it time to revise the consensus definition?

Authors:  Mahya Faghih; Amitasha Sinha; Robert A Moran; Elham Afghani; Yuval A Patel; Andrew C Storm; Ayesha Kamal; Venkata S Akshintala; Atif Zaheer; Anthony N Kalloo; Vivek Kumbhari; Mouen A Khashab; Vikesh K Singh
Journal:  Endosc Int Open       Date:  2018-07-04

10.  Risk of endoscopic biliary interventions in primary sclerosing cholangitis is similar between patients with and without cirrhosis.

Authors:  Moritz Peiseler; David Reiners; Hans O Pinnschmidt; Marcial Sebode; Franziska Jung; Johannes Hartl; Roman Zenouzi; Hanno Ehlken; Stefan Groth; Guido Schachschal; Thomas Rösch; Christina Weiler-Normann; Ansgar W Lohse; Christoph Schramm
Journal:  PLoS One       Date:  2018-08-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.